What is the projected market valuation of the Feed Vitamins Market by 2035?

The Feed Vitamins Market is projected to reach a valuation of 9.705 USD Billion by 2035. Read More

What was the market valuation of the Feed Vitamins Market in 2024?

In 2024, the Feed Vitamins Market was valued at 5.98 USD Billion. Read More

What is the expected CAGR for the Feed Vitamins Market during the forecast period 2025 - 2035?

The expected CAGR for the Feed Vitamins Market during the forecast period 2025 - 2035 is 4.5%. Read More

Which segment of the Feed Vitamins Market had the highest valuation in 2024?

In 2024, the Ruminant Nutrition and Poultry Nutrition segments each had a valuation of 1.79 USD Billion. Read More

What is the projected valuation for the Swine Nutrition segment by 2035?

The Swine Nutrition segment is projected to reach a valuation of 1.85 USD Billion by 2035. Read More

Which vitamin type is expected to have the highest market valuation by 2035?

Vitamin A is expected to have the highest market valuation, projected at 2.4 USD Billion by 2035. Read More

What form of feed vitamins is anticipated to dominate the market by 2035?

The Powder form of feed vitamins is anticipated to dominate the market, projected to reach 3.75 USD Billion by 2035. Read More

What is the projected valuation for the Pet Care segment by 2035?

The Pet Care segment is projected to reach a valuation of 3.17 USD Billion by 2035. Read More

Who are the key players in the Feed Vitamins Market?

Key players in the Feed Vitamins Market include BASF SE, Cargill, Incorporated, and Nutreco N.V. Read More

What is the expected growth trend for the Aquaculture Nutrition segment by 2035?

The Aquaculture Nutrition segment is expected to grow to a valuation of 1.25 USD Billion by 2035. Read More

Feed Vitamins Market

ID: MRFR/Agri/40197-HCR

128 Pages

Snehal Singh

Last Updated: April 06, 2026

Feed Vitamins Market Size, Share, Industry Trend & Analysis Research Report By Application (Ruminant Nutrition, Poultry Nutrition, Swine Nutrition, Aquaculture Nutrition, Pet Nutrition), By Vitamin Type (Vitamin A, Vitamin D, Vitamin E, Vitamin K, B Vitamins), By Form (Liquid, Powder, Granules, Tablets), By End Use (Commercial Farming, Household Farming, Pet Care) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035.

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1.1 EXECUTIVE SUMMARY
1.1.1 Market Overview
1.1.2 Key Findings
1.1.3 Market Segmentation
1.1.4 Competitive Landscape
1.1.5 Challenges and Opportunities
1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
2.1 MARKET INTRODUCTION
2.1.1 Definition
2.1.2 Scope of the study
2.1.2.1 Research Objective
2.1.2.2 Assumption
2.1.2.3 Limitations
2.2 RESEARCH METHODOLOGY
2.2.1 Overview
2.2.2 Data Mining
2.2.3 Secondary Research
2.2.4 Primary Research
2.2.4.1 Primary Interviews and Information Gathering Process
2.2.4.2 Breakdown of Primary Respondents
2.2.5 Forecasting Model
2.2.6 Market Size Estimation
2.2.6.1 Bottom-Up Approach
2.2.6.2 Top-Down Approach
2.2.7 Data Triangulation
2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
3.1 MARKET DYNAMICS
3.1.1 Overview
3.1.2 Drivers
3.1.3 Restraints
3.1.4 Opportunities
3.2 MARKET FACTOR ANALYSIS
3.2.1 Value chain Analysis
3.2.2 Porter's Five Forces Analysis
3.2.2.1 Bargaining Power of Suppliers
3.2.2.2 Bargaining Power of Buyers
3.2.2.3 Threat of New Entrants
3.2.2.4 Threat of Substitutes
3.2.2.5 Intensity of Rivalry
3.2.3 COVID-19 Impact Analysis
3.2.3.1 Market Impact Analysis
3.2.3.2 Regional Impact
3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
4.1 Industrial Automation & Equipment, BY Application (USD Billion)
4.1.1 Ruminant Nutrition
4.1.2 Poultry Nutrition
4.1.3 Swine Nutrition
4.1.4 Aquaculture Nutrition
4.1.5 Pet Nutrition
4.2 Industrial Automation & Equipment, BY Vitamin Type (USD Billion)
4.2.1 Vitamin A
4.2.2 Vitamin D
4.2.3 Vitamin E
4.2.4 Vitamin K
4.2.5 B Vitamins
4.3 Industrial Automation & Equipment, BY Form (USD Billion)
4.3.1 Liquid
4.3.2 Powder
4.3.3 Granules
4.3.4 Tablets
4.4 Industrial Automation & Equipment, BY End Use (USD Billion)
4.4.1 Commercial Farming
4.4.2 Household Farming
4.4.3 Pet Care
4.5 Industrial Automation & Equipment, BY Region (USD Billion)
4.5.1 North America
4.5.1.1 US
4.5.1.2 Canada
4.5.2 Europe
4.5.2.1 Germany
4.5.2.2 UK
4.5.2.3 France
4.5.2.4 Russia
4.5.2.5 Italy
4.5.2.6 Spain
4.5.2.7 Rest of Europe
4.5.3 APAC
4.5.3.1 China
4.5.3.2 India
4.5.3.3 Japan
4.5.3.4 South Korea
4.5.3.5 Malaysia
4.5.3.6 Thailand
4.5.3.7 Indonesia
4.5.3.8 Rest of APAC
4.5.4 South America
4.5.4.1 Brazil
4.5.4.2 Mexico
4.5.4.3 Argentina
4.5.4.4 Rest of South America
4.5.5 MEA
4.5.5.1 GCC Countries
4.5.5.2 South Africa
4.5.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
5.1 Competitive Landscape
5.1.1 Overview
5.1.2 Competitive Analysis
5.1.3 Market share Analysis
5.1.4 Major Growth Strategy in the Industrial Automation & Equipment
5.1.5 Competitive Benchmarking
5.1.6 Leading Players in Terms of Number of Developments in the Industrial Automation & Equipment
5.1.7 Key developments and growth strategies
5.1.7.1 New Product Launch/Service Deployment
5.1.7.2 Merger & Acquisitions
5.1.7.3 Joint Ventures
5.1.8 Major Players Financial Matrix
5.1.8.1 Sales and Operating Income
5.1.8.2 Major Players R&D Expenditure. 2023
5.2 Company Profiles
5.2.1 BASF SE (DE)
5.2.1.1 Financial Overview
5.2.1.2 Products Offered
5.2.1.3 Key Developments
5.2.1.4 SWOT Analysis
5.2.1.5 Key Strategies
5.2.2 Cargill, Incorporated (US)
5.2.2.1 Financial Overview
5.2.2.2 Products Offered
5.2.2.3 Key Developments
5.2.2.4 SWOT Analysis
5.2.2.5 Key Strategies
5.2.3 Nutreco N.V. (NL)
5.2.3.1 Financial Overview
5.2.3.2 Products Offered
5.2.3.3 Key Developments
5.2.3.4 SWOT Analysis
5.2.3.5 Key Strategies
5.2.4 Alltech, Inc. (US)
5.2.4.1 Financial Overview
5.2.4.2 Products Offered
5.2.4.3 Key Developments
5.2.4.4 SWOT Analysis
5.2.4.5 Key Strategies
5.2.5 Evonik Industries AG (DE)
5.2.5.1 Financial Overview
5.2.5.2 Products Offered
5.2.5.3 Key Developments
5.2.5.4 SWOT Analysis
5.2.5.5 Key Strategies
5.2.6 ADM (US)
5.2.6.1 Financial Overview
5.2.6.2 Products Offered
5.2.6.3 Key Developments
5.2.6.4 SWOT Analysis
5.2.6.5 Key Strategies
5.2.7 Kemin Industries, Inc. (US)
5.2.7.1 Financial Overview
5.2.7.2 Products Offered
5.2.7.3 Key Developments
5.2.7.4 SWOT Analysis
5.2.7.5 Key Strategies
5.2.8 Royal DSM N.V. (NL)
5.2.8.1 Financial Overview
5.2.8.2 Products Offered
5.2.8.3 Key Developments
5.2.8.4 SWOT Analysis
5.2.8.5 Key Strategies
5.2.9 Novus International, Inc. (US)
5.2.9.1 Financial Overview
5.2.9.2 Products Offered
5.2.9.3 Key Developments
5.2.9.4 SWOT Analysis
5.2.9.5 Key Strategies
5.3 Appendix
5.3.1 References
5.3.2 Related Reports
6 LIST OF FIGURES
6.1 MARKET SYNOPSIS
6.2 NORTH AMERICA MARKET ANALYSIS
6.3 US MARKET ANALYSIS BY APPLICATION
6.4 US MARKET ANALYSIS BY VITAMIN TYPE
6.5 US MARKET ANALYSIS BY FORM
6.6 US MARKET ANALYSIS BY END USE
6.7 CANADA MARKET ANALYSIS BY APPLICATION
6.8 CANADA MARKET ANALYSIS BY VITAMIN TYPE
6.9 CANADA MARKET ANALYSIS BY FORM
6.10 CANADA MARKET ANALYSIS BY END USE
6.11 EUROPE MARKET ANALYSIS
6.12 GERMANY MARKET ANALYSIS BY APPLICATION
6.13 GERMANY MARKET ANALYSIS BY VITAMIN TYPE
6.14 GERMANY MARKET ANALYSIS BY FORM
6.15 GERMANY MARKET ANALYSIS BY END USE
6.16 UK MARKET ANALYSIS BY APPLICATION
6.17 UK MARKET ANALYSIS BY VITAMIN TYPE
6.18 UK MARKET ANALYSIS BY FORM
6.19 UK MARKET ANALYSIS BY END USE
6.20 FRANCE MARKET ANALYSIS BY APPLICATION
6.21 FRANCE MARKET ANALYSIS BY VITAMIN TYPE
6.22 FRANCE MARKET ANALYSIS BY FORM
6.23 FRANCE MARKET ANALYSIS BY END USE
6.24 RUSSIA MARKET ANALYSIS BY APPLICATION
6.25 RUSSIA MARKET ANALYSIS BY VITAMIN TYPE
6.26 RUSSIA MARKET ANALYSIS BY FORM
6.27 RUSSIA MARKET ANALYSIS BY END USE
6.28 ITALY MARKET ANALYSIS BY APPLICATION
6.29 ITALY MARKET ANALYSIS BY VITAMIN TYPE
6.30 ITALY MARKET ANALYSIS BY FORM
6.31 ITALY MARKET ANALYSIS BY END USE
6.32 SPAIN MARKET ANALYSIS BY APPLICATION
6.33 SPAIN MARKET ANALYSIS BY VITAMIN TYPE
6.34 SPAIN MARKET ANALYSIS BY FORM
6.35 SPAIN MARKET ANALYSIS BY END USE
6.36 REST OF EUROPE MARKET ANALYSIS BY APPLICATION
6.37 REST OF EUROPE MARKET ANALYSIS BY VITAMIN TYPE
6.38 REST OF EUROPE MARKET ANALYSIS BY FORM
6.39 REST OF EUROPE MARKET ANALYSIS BY END USE
6.40 APAC MARKET ANALYSIS
6.41 CHINA MARKET ANALYSIS BY APPLICATION
6.42 CHINA MARKET ANALYSIS BY VITAMIN TYPE
6.43 CHINA MARKET ANALYSIS BY FORM
6.44 CHINA MARKET ANALYSIS BY END USE
6.45 INDIA MARKET ANALYSIS BY APPLICATION
6.46 INDIA MARKET ANALYSIS BY VITAMIN TYPE
6.47 INDIA MARKET ANALYSIS BY FORM
6.48 INDIA MARKET ANALYSIS BY END USE
6.49 JAPAN MARKET ANALYSIS BY APPLICATION
6.50 JAPAN MARKET ANALYSIS BY VITAMIN TYPE
6.51 JAPAN MARKET ANALYSIS BY FORM
6.52 JAPAN MARKET ANALYSIS BY END USE
6.53 SOUTH KOREA MARKET ANALYSIS BY APPLICATION
6.54 SOUTH KOREA MARKET ANALYSIS BY VITAMIN TYPE
6.55 SOUTH KOREA MARKET ANALYSIS BY FORM
6.56 SOUTH KOREA MARKET ANALYSIS BY END USE
6.57 MALAYSIA MARKET ANALYSIS BY APPLICATION
6.58 MALAYSIA MARKET ANALYSIS BY VITAMIN TYPE
6.59 MALAYSIA MARKET ANALYSIS BY FORM
6.60 MALAYSIA MARKET ANALYSIS BY END USE
6.61 THAILAND MARKET ANALYSIS BY APPLICATION
6.62 THAILAND MARKET ANALYSIS BY VITAMIN TYPE
6.63 THAILAND MARKET ANALYSIS BY FORM
6.64 THAILAND MARKET ANALYSIS BY END USE
6.65 INDONESIA MARKET ANALYSIS BY APPLICATION
6.66 INDONESIA MARKET ANALYSIS BY VITAMIN TYPE
6.67 INDONESIA MARKET ANALYSIS BY FORM
6.68 INDONESIA MARKET ANALYSIS BY END USE
6.69 REST OF APAC MARKET ANALYSIS BY APPLICATION
6.70 REST OF APAC MARKET ANALYSIS BY VITAMIN TYPE
6.71 REST OF APAC MARKET ANALYSIS BY FORM
6.72 REST OF APAC MARKET ANALYSIS BY END USE
6.73 SOUTH AMERICA MARKET ANALYSIS
6.74 BRAZIL MARKET ANALYSIS BY APPLICATION
6.75 BRAZIL MARKET ANALYSIS BY VITAMIN TYPE
6.76 BRAZIL MARKET ANALYSIS BY FORM
6.77 BRAZIL MARKET ANALYSIS BY END USE
6.78 MEXICO MARKET ANALYSIS BY APPLICATION
6.79 MEXICO MARKET ANALYSIS BY VITAMIN TYPE
6.80 MEXICO MARKET ANALYSIS BY FORM
6.81 MEXICO MARKET ANALYSIS BY END USE
6.82 ARGENTINA MARKET ANALYSIS BY APPLICATION
6.83 ARGENTINA MARKET ANALYSIS BY VITAMIN TYPE
6.84 ARGENTINA MARKET ANALYSIS BY FORM
6.85 ARGENTINA MARKET ANALYSIS BY END USE
6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY APPLICATION
6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY VITAMIN TYPE
6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY FORM
6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USE
6.90 MEA MARKET ANALYSIS
6.91 GCC COUNTRIES MARKET ANALYSIS BY APPLICATION
6.92 GCC COUNTRIES MARKET ANALYSIS BY VITAMIN TYPE
6.93 GCC COUNTRIES MARKET ANALYSIS BY FORM
6.94 GCC COUNTRIES MARKET ANALYSIS BY END USE
6.95 SOUTH AFRICA MARKET ANALYSIS BY APPLICATION
6.96 SOUTH AFRICA MARKET ANALYSIS BY VITAMIN TYPE
6.97 SOUTH AFRICA MARKET ANALYSIS BY FORM
6.98 SOUTH AFRICA MARKET ANALYSIS BY END USE
6.99 REST OF MEA MARKET ANALYSIS BY APPLICATION
6.100 REST OF MEA MARKET ANALYSIS BY VITAMIN TYPE
6.101 REST OF MEA MARKET ANALYSIS BY FORM
6.102 REST OF MEA MARKET ANALYSIS BY END USE
6.103 KEY BUYING CRITERIA OF INDUSTRIAL AUTOMATION & EQUIPMENT
6.104 RESEARCH PROCESS OF MRFR
6.105 DRO ANALYSIS OF INDUSTRIAL AUTOMATION & EQUIPMENT
6.106 DRIVERS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
6.107 RESTRAINTS IMPACT ANALYSIS: INDUSTRIAL AUTOMATION & EQUIPMENT
6.108 SUPPLY / VALUE CHAIN: INDUSTRIAL AUTOMATION & EQUIPMENT
6.109 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 (% SHARE)
6.110 INDUSTRIAL AUTOMATION & EQUIPMENT, BY APPLICATION, 2024 TO 2035 (USD Billion)
6.111 INDUSTRIAL AUTOMATION & EQUIPMENT, BY VITAMIN TYPE, 2024 (% SHARE)
6.112 INDUSTRIAL AUTOMATION & EQUIPMENT, BY VITAMIN TYPE, 2024 TO 2035 (USD Billion)
6.113 INDUSTRIAL AUTOMATION & EQUIPMENT, BY FORM, 2024 (% SHARE)
6.114 INDUSTRIAL AUTOMATION & EQUIPMENT, BY FORM, 2024 TO 2035 (USD Billion)
6.115 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USE, 2024 (% SHARE)
6.116 INDUSTRIAL AUTOMATION & EQUIPMENT, BY END USE, 2024 TO 2035 (USD Billion)
6.117 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
7.1 LIST OF ASSUMPTIONS
7.1.1
7.2 North America MARKET SIZE ESTIMATES; FORECAST
7.2.1 BY APPLICATION, 2025-2035 (USD Billion)
7.2.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.2.3 BY FORM, 2025-2035 (USD Billion)
7.2.4 BY END USE, 2025-2035 (USD Billion)
7.3 US MARKET SIZE ESTIMATES; FORECAST
7.3.1 BY APPLICATION, 2025-2035 (USD Billion)
7.3.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.3.3 BY FORM, 2025-2035 (USD Billion)
7.3.4 BY END USE, 2025-2035 (USD Billion)
7.4 Canada MARKET SIZE ESTIMATES; FORECAST
7.4.1 BY APPLICATION, 2025-2035 (USD Billion)
7.4.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.4.3 BY FORM, 2025-2035 (USD Billion)
7.4.4 BY END USE, 2025-2035 (USD Billion)
7.5 Europe MARKET SIZE ESTIMATES; FORECAST
7.5.1 BY APPLICATION, 2025-2035 (USD Billion)
7.5.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.5.3 BY FORM, 2025-2035 (USD Billion)
7.5.4 BY END USE, 2025-2035 (USD Billion)
7.6 Germany MARKET SIZE ESTIMATES; FORECAST
7.6.1 BY APPLICATION, 2025-2035 (USD Billion)
7.6.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.6.3 BY FORM, 2025-2035 (USD Billion)
7.6.4 BY END USE, 2025-2035 (USD Billion)
7.7 UK MARKET SIZE ESTIMATES; FORECAST
7.7.1 BY APPLICATION, 2025-2035 (USD Billion)
7.7.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.7.3 BY FORM, 2025-2035 (USD Billion)
7.7.4 BY END USE, 2025-2035 (USD Billion)
7.8 France MARKET SIZE ESTIMATES; FORECAST
7.8.1 BY APPLICATION, 2025-2035 (USD Billion)
7.8.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.8.3 BY FORM, 2025-2035 (USD Billion)
7.8.4 BY END USE, 2025-2035 (USD Billion)
7.9 Russia MARKET SIZE ESTIMATES; FORECAST
7.9.1 BY APPLICATION, 2025-2035 (USD Billion)
7.9.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.9.3 BY FORM, 2025-2035 (USD Billion)
7.9.4 BY END USE, 2025-2035 (USD Billion)
7.10 Italy MARKET SIZE ESTIMATES; FORECAST
7.10.1 BY APPLICATION, 2025-2035 (USD Billion)
7.10.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.10.3 BY FORM, 2025-2035 (USD Billion)
7.10.4 BY END USE, 2025-2035 (USD Billion)
7.11 Spain MARKET SIZE ESTIMATES; FORECAST
7.11.1 BY APPLICATION, 2025-2035 (USD Billion)
7.11.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.11.3 BY FORM, 2025-2035 (USD Billion)
7.11.4 BY END USE, 2025-2035 (USD Billion)
7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
7.12.1 BY APPLICATION, 2025-2035 (USD Billion)
7.12.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.12.3 BY FORM, 2025-2035 (USD Billion)
7.12.4 BY END USE, 2025-2035 (USD Billion)
7.13 APAC MARKET SIZE ESTIMATES; FORECAST
7.13.1 BY APPLICATION, 2025-2035 (USD Billion)
7.13.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.13.3 BY FORM, 2025-2035 (USD Billion)
7.13.4 BY END USE, 2025-2035 (USD Billion)
7.14 China MARKET SIZE ESTIMATES; FORECAST
7.14.1 BY APPLICATION, 2025-2035 (USD Billion)
7.14.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.14.3 BY FORM, 2025-2035 (USD Billion)
7.14.4 BY END USE, 2025-2035 (USD Billion)
7.15 India MARKET SIZE ESTIMATES; FORECAST
7.15.1 BY APPLICATION, 2025-2035 (USD Billion)
7.15.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.15.3 BY FORM, 2025-2035 (USD Billion)
7.15.4 BY END USE, 2025-2035 (USD Billion)
7.16 Japan MARKET SIZE ESTIMATES; FORECAST
7.16.1 BY APPLICATION, 2025-2035 (USD Billion)
7.16.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.16.3 BY FORM, 2025-2035 (USD Billion)
7.16.4 BY END USE, 2025-2035 (USD Billion)
7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
7.17.1 BY APPLICATION, 2025-2035 (USD Billion)
7.17.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.17.3 BY FORM, 2025-2035 (USD Billion)
7.17.4 BY END USE, 2025-2035 (USD Billion)
7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
7.18.1 BY APPLICATION, 2025-2035 (USD Billion)
7.18.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.18.3 BY FORM, 2025-2035 (USD Billion)
7.18.4 BY END USE, 2025-2035 (USD Billion)
7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
7.19.1 BY APPLICATION, 2025-2035 (USD Billion)
7.19.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.19.3 BY FORM, 2025-2035 (USD Billion)
7.19.4 BY END USE, 2025-2035 (USD Billion)
7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
7.20.1 BY APPLICATION, 2025-2035 (USD Billion)
7.20.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.20.3 BY FORM, 2025-2035 (USD Billion)
7.20.4 BY END USE, 2025-2035 (USD Billion)
7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
7.21.1 BY APPLICATION, 2025-2035 (USD Billion)
7.21.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.21.3 BY FORM, 2025-2035 (USD Billion)
7.21.4 BY END USE, 2025-2035 (USD Billion)
7.22 South America MARKET SIZE ESTIMATES; FORECAST
7.22.1 BY APPLICATION, 2025-2035 (USD Billion)
7.22.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.22.3 BY FORM, 2025-2035 (USD Billion)
7.22.4 BY END USE, 2025-2035 (USD Billion)
7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
7.23.1 BY APPLICATION, 2025-2035 (USD Billion)
7.23.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.23.3 BY FORM, 2025-2035 (USD Billion)
7.23.4 BY END USE, 2025-2035 (USD Billion)
7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
7.24.1 BY APPLICATION, 2025-2035 (USD Billion)
7.24.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.24.3 BY FORM, 2025-2035 (USD Billion)
7.24.4 BY END USE, 2025-2035 (USD Billion)
7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
7.25.1 BY APPLICATION, 2025-2035 (USD Billion)
7.25.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.25.3 BY FORM, 2025-2035 (USD Billion)
7.25.4 BY END USE, 2025-2035 (USD Billion)
7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
7.26.1 BY APPLICATION, 2025-2035 (USD Billion)
7.26.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.26.3 BY FORM, 2025-2035 (USD Billion)
7.26.4 BY END USE, 2025-2035 (USD Billion)
7.27 MEA MARKET SIZE ESTIMATES; FORECAST
7.27.1 BY APPLICATION, 2025-2035 (USD Billion)
7.27.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.27.3 BY FORM, 2025-2035 (USD Billion)
7.27.4 BY END USE, 2025-2035 (USD Billion)
7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
7.28.1 BY APPLICATION, 2025-2035 (USD Billion)
7.28.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.28.3 BY FORM, 2025-2035 (USD Billion)
7.28.4 BY END USE, 2025-2035 (USD Billion)
7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
7.29.1 BY APPLICATION, 2025-2035 (USD Billion)
7.29.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.29.3 BY FORM, 2025-2035 (USD Billion)
7.29.4 BY END USE, 2025-2035 (USD Billion)
7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
7.30.1 BY APPLICATION, 2025-2035 (USD Billion)
7.30.2 BY VITAMIN TYPE, 2025-2035 (USD Billion)
7.30.3 BY FORM, 2025-2035 (USD Billion)
7.30.4 BY END USE, 2025-2035 (USD Billion)
7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Industrial Automation & Equipment Market Segmentation

Industrial Automation & Equipment By Application (USD Billion, 2025-2035)

Ruminant Nutrition
Poultry Nutrition
Swine Nutrition
Aquaculture Nutrition
Pet Nutrition

Industrial Automation & Equipment By Vitamin Type (USD Billion, 2025-2035)

Vitamin A
Vitamin D
Vitamin E
Vitamin K
B Vitamins

Industrial Automation & Equipment By Form (USD Billion, 2025-2035)

Liquid
Powder
Granules
Tablets

Industrial Automation & Equipment By End Use (USD Billion, 2025-2035)

Commercial Farming
Household Farming
Pet Care

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓